BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights
Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System for Treatment of Anxious Depression...
Day: November 17, 2021
Update on Regulatory Review of Aducanumab in the European Union
CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) announced today...
Minerva Surgical Launches Educational Website for Women Living with Abnormal Uterine Bleeding
AUBandMe.com debuts at the American Association of Gynecologic Laparoscopists 50th Global CongressSANTA CLARA, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) --...
iSTAR Medical receives European market approval for glaucoma implant MINIject
iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma...
The University of Pittsburgh and Orange Grove Bio Establish Partnership to Develop and Commercialize Novel Therapeutics
NEW YORK and PITTSBURGH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm,...
Oncorus to Present at the Jefferies London Healthcare Conference
CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation...
Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021
Webcast and Conference Call To be Held Wednesday November 24, 2021, 4:30 pm EDTNEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE)...
Ceapro Inc. Reports Preliminary Results from Clinical Trial Evaluating Oat Beta Glucan in Patients with High Cholesterol Levels
EDMONTON, Alberta, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage...
Zentalis Pharmaceuticals Announces Fast Track Designation Granted by the U.S. FDA to ZN-c3 for the Treatment of Uterine Serous Carcinoma
Potentially registrational Phase 2 trial of ZN-c3 in USC is underway, with initial enrollment and safety update expected in 2H...
Microbix Expands Pandemic Test Controls (QAPs™) Portfolio
Helping Ensure Workflow Accuracy of PCR Tests for COVID “Variants of Concern”MISSISSAUGA, Ontario, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Microbix...
ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of Directors
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 17, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the...
Jushi Holdings Inc. Reports Third Quarter 2021 Financial Results
Third Quarter 2021 Revenue Increased 116.7% to $54.0 million as Compared to the Third Quarter 2020; Net Income of $38.2...
New White Paper Highlights Barriers and Opportunities to Drive Biosimilar Adoption in the United States
Healthcare professionals can benefit from more education to address knowledge gaps about the FDA’s robust evaluation, review, and approval standards...
Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2 Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients
ELX-02 monotherapy dosed at 1.5mg/kg/day demonstrated a statistically significant 5.4mmol/L mean sweat chloride reduction, an established surrogate for restoration of...
A Second Independent Proxy Advisor, ISS, Recommends Promis Neurosciences Shareholders Vote for the Share Consolidation
For any questions, please contact ProMIS’ proxy solicitation agent, Laurel Hill Advisory Group at 1-877- 452-7184 (+1-416-304-0211 outside North America)...
Jushi Holdings Inc. Further Expands Nevada Footprint Through Agreement to Acquire Vertically Integrated State Operator
Acquisition Includes Three Retail Dispensaries, a Cultivation Facility and a Product Manufacturing Facility Expands Jushi’s presence in Nevada’s attractive limited...
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
– US government contracts for approximately $1 billion1 (USD) now in place to purchase sotrovimab, further expanding access nationwide – –...
The Ensign Group Acquires Real Estate in Arizona, California and Kansas
SAN JUAN CAPISTRANO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group...
Nomination Committee appointed for the Annual General Meeting 2022 in LIDDS
November 17, 2021 Nomination Committee appointed for the Annual General Meeting 2022 in LIDDS UPPSALA, SWEDEN – LIDDS AB (publ)...
Bloom Health Partners Announces Upgrade to the OTCQB Markets and Atlanta Expansion
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2021) - Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D84) ("Bloom"),...
